Breakthrough DNA Analysis Technology to Hasten Problem Diagnosis
|
By LabMedica International staff writers Posted on 25 Aug 2014 |

Image: A technical breakthrough for DNA imaging has been achieved that should quicken diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various pre-natal conditions (Photo courtesy of McGill University and Génome Québec Innovation Center).
Researchers have achieved a technical breakthrough that should result in speedier diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various prenatal conditions.
The key discovery lies in a new tool developed by a team led by Sabrina Leslie and Walter Reisner, both professors of physics at McGill University (Montreal, QC, Canada), and their collaborator Dr. Rob Sladek of the McGill University & Génome Québec Innovation Center (MUGQ Innovation Center; Montreal, Quebec, Canada). The tool enables the loading of long strands of DNA into a tunable nanoscale imaging chamber in ways that maintain structural identity and conditions similar to their in vivo physiology. This breakthrough method – “Convex Lens-Induced Confinement” (CLIC) (also referred to as convex lens-induced nanoscale templating (CLINT)) – will permit a rapid imaging-based mapping of large genomes while simultaneously identifying specific gene sequences from single cells with single-molecule resolution, a process critical to diagnosing certain types of diseases.
Existing tools used for single-cell genomic analysis rely on side-loading DNA and under pressure into nanochannels in the imaging chamber, a practice that breaks the DNA molecules into small pieces, making it a challenge to later reconstruct the genome. The CLIC tool can be set on top of a standard inverted fluorescence microscope and its innovative aspect lies in the fact that it allows strands of DNA to be loaded into the imaging chamber – from above – and in a process that allows the strands of DNA to maintain their integrity.
“It’s like squeezing many soft spaghetti noodles into long narrow tubes without breaking them,” explains Prof. Leslie, “Once these long strands of DNA are gently squeezed down into nanochannels from a nanoscale bath above, they become effectively rigid which means that we can map positions along uniformly stretched strands of DNA, while holding them still. This means diagnostics can be performed quickly, one cell at a time, which is critical for diagnosing many prenatal conditions and the onset of cancer.”
“Current practices of genomic analysis typically require tens of thousands of cells worth of genomic material to obtain the information we need, but this new approach works with single cells,” said Dr. Sladek, “CLIC will allow researchers to avoid having to spend time stitching together maps of entire genomes as we do under current techniques, and promises to make genomic analysis a much simpler and more efficient process.”
“Nanoscale physics has so much to offer biomedicine and diagnostics,” added Prof. Leslie, “CLIC brings the nanoscale regime to the bench top, and genomics is just the beginning”.
The work was described by Berarda DJ et al. in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), August 4, 2014, online ahead of print.
Related Links:
McGill University
The McGill University and Génome Québec Innovation Center
The key discovery lies in a new tool developed by a team led by Sabrina Leslie and Walter Reisner, both professors of physics at McGill University (Montreal, QC, Canada), and their collaborator Dr. Rob Sladek of the McGill University & Génome Québec Innovation Center (MUGQ Innovation Center; Montreal, Quebec, Canada). The tool enables the loading of long strands of DNA into a tunable nanoscale imaging chamber in ways that maintain structural identity and conditions similar to their in vivo physiology. This breakthrough method – “Convex Lens-Induced Confinement” (CLIC) (also referred to as convex lens-induced nanoscale templating (CLINT)) – will permit a rapid imaging-based mapping of large genomes while simultaneously identifying specific gene sequences from single cells with single-molecule resolution, a process critical to diagnosing certain types of diseases.
Existing tools used for single-cell genomic analysis rely on side-loading DNA and under pressure into nanochannels in the imaging chamber, a practice that breaks the DNA molecules into small pieces, making it a challenge to later reconstruct the genome. The CLIC tool can be set on top of a standard inverted fluorescence microscope and its innovative aspect lies in the fact that it allows strands of DNA to be loaded into the imaging chamber – from above – and in a process that allows the strands of DNA to maintain their integrity.
“It’s like squeezing many soft spaghetti noodles into long narrow tubes without breaking them,” explains Prof. Leslie, “Once these long strands of DNA are gently squeezed down into nanochannels from a nanoscale bath above, they become effectively rigid which means that we can map positions along uniformly stretched strands of DNA, while holding them still. This means diagnostics can be performed quickly, one cell at a time, which is critical for diagnosing many prenatal conditions and the onset of cancer.”
“Current practices of genomic analysis typically require tens of thousands of cells worth of genomic material to obtain the information we need, but this new approach works with single cells,” said Dr. Sladek, “CLIC will allow researchers to avoid having to spend time stitching together maps of entire genomes as we do under current techniques, and promises to make genomic analysis a much simpler and more efficient process.”
“Nanoscale physics has so much to offer biomedicine and diagnostics,” added Prof. Leslie, “CLIC brings the nanoscale regime to the bench top, and genomics is just the beginning”.
The work was described by Berarda DJ et al. in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), August 4, 2014, online ahead of print.
Related Links:
McGill University
The McGill University and Génome Québec Innovation Center
Latest Technology News
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
- Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
- Online Tool Supports Family Screening for Inherited Cancer Risk
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- AI Model Outperforms Clinicians in Rare Disease Detection
- AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
- Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
- AI-Powered Biomarker Predicts Liver Cancer Risk
Channels
Clinical Chemistry
view channel
Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
High blood pressure during pregnancy is common and can progress to pre-eclampsia, making close monitoring at antenatal visits essential. However, most risk assessment begins only after pregnancy has started.... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring
Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response
Immunotherapy has transformed cancer care, yet durable benefit remains limited to a subset of patients, and clinicians still lack reliable tools to predict response before treatment begins.... Read more
Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing
Respiratory infections drive heavy testing volumes in clinical laboratories, where accurate, timely results across multiple pathogens are essential. Many labs are seeking to streamline workflows and increase... Read moreHematology
view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Bone marrow biopsies remain central to diagnosing and monitoring multiple myeloma, yet the procedure is painful, invasive, and often repeated over time. Older patients—who represent most new cases—can... Read moreImmunology
view channel
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Mpox outbreaks in non-endemic regions have underscored the need for rapid, accessible diagnostics to limit transmission. Polymerase chain reaction (PCR) remains the clinical reference, yet it depends on... Read more
T-Cell Senescence Profiling May Predict CAR T Responses
Chimeric antigen receptor (CAR) T-cell therapy can deliver striking, durable remissions, yet many patients experience minimal or no benefit. The quality of patient-derived cytotoxic T lymphocytes used... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreIndustry
view channel
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more








